X

Month: April 2023

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a…

What to expect when Netflix (NFLX) reports Q1 2023 earnings next week

Shares of Netflix, Inc. (NASDAQ: NFLX) were up slightly on Tuesday. The stock has gained 15% year-to-date and 3% over…

Key factors to consider before investing in Abbott Laboratories (ABT)

Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues…

Infographic: Highlights of Tilray’s Q3 2023 financial results

Cannabis company Tilray (NASDAQ: TLRY) has announced financial results for the third quarter of 2023, reporting a net loss and…

Infographic: Key highlights from CarMax’s (KMX) Q4 2023 earnings results

CarMax, Inc. (NYSE: KMX) reported fourth quarter 2023 earnings results today. Net revenues were $5.7 billion, down 25.6% compared to…

Here’s why you should add BlackRock (BLK) stock to your portfolio

Over the years, investment management company BlackRock Inc (NYSE: BLK) has thrived on its diversified business model and continued focus…

Lamb Weston (LW): A look at the headwinds and tailwinds for this potato products maker

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) were down slightly on Monday. The stock has gained 19% year-to-date and…

Can Fastenal (FAST) extend the strong momentum into 2023?

Fastenal Company (NASDAQ: FAST), a leading distributor of industrial and construction supplies, has constantly innovated its product portfolio by adopting…

Key takeaways from Constellation Brands’ Q4 earnings report

Shares of Constellation Brands, Inc. (NYSE: STZ) were up 1% on Thursday, after the company reported its earnings results for…

Ocean Biomedical (OCEA) announces new findings in relation to treatment options for Hermansky-Pudlak Syndrome

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) announced its commitment to developing viable treatment options for Hermansky-Pudlak Syndrome (HPS) on…